ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NTLA Intellia Therapeutics Inc

24.045
1.05 (4.54%)
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Intellia Therapeutics Inc NTLA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.05 4.54% 24.045 10:00:00
Open Price Low Price High Price Close Price Previous Close
24.29 23.35 24.88 23.00
more quote information »

Recent News

Date Time Source Heading
5/09/202406:40EDGAR2Form 8-K - Current report
5/09/202406:30GLOBEIntellia Therapeutics Announces First Quarter 2024 Financial..
5/02/202406:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
4/29/202406:30GLOBEIntellia Therapeutics to Present Updated Data from Phase 1/2..
3/18/202406:30GLOBEIntellia Therapeutics Announces First Patient Dosed in the..
3/05/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202406:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/23/202416:17EDGAR2Form 8-K - Current report
2/22/202415:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/22/202415:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/22/202406:45EDGAR2Form 8-K - Current report
2/22/202406:30GLOBEIntellia Therapeutics Announces Fourth Quarter and Full-Year..
2/15/202406:30GLOBEIntellia Therapeutics and ReCode Therapeutics Announce..
2/14/202406:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
2/01/202415:05EDGAR2Form 8-K - Current report
1/31/202416:00GLOBEIntellia Therapeutics Announces Publication of Positive..
1/29/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/10/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202415:05EDGAR2Form 144 - Report of proposed sale of securities
1/05/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:07EDGAR2Form 8-K - Current report
1/04/202415:01GLOBEIntellia Therapeutics Highlights its Three-Year Strategic..
1/03/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/06/202306:00EDGAR2Form 8-K - Current report
11/24/202308:30EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/14/202306:30GLOBEIntellia Therapeutics Receives European Union Orphan Drug..
11/09/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202306:45EDGAR2Form 8-K - Current report
11/09/202306:30GLOBEIntellia Therapeutics Announces Third Quarter 2023 Financial..
11/02/202315:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202306:11EDGAR2Form 8-K - Current report
11/02/202306:00GLOBEIntellia Presents New Interim Data from the Ongoing Phase 1..
10/26/202306:30GLOBEIntellia Therapeutics to Present Updated Data from Ongoing..
10/18/202306:30EDGAR2Form 8-K - Current report
10/18/202306:00GLOBEIntellia Therapeutics Announces FDA Clearance of..
10/13/202307:38GLOBEIntellia Therapeutics Receives Priority Medicines (PRIME)..
10/03/202306:19EDGAR2Form 8-K - Current report
10/03/202306:00GLOBERegeneron and Intellia Announce Expanded Research..
8/03/202315:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202306:45EDGAR2Form 8-K - Current report
8/03/202306:30GLOBEIntellia Therapeutics Announces Second Quarter 2023..

Your Recent History

Delayed Upgrade Clock